FORT LAUDERDALE, Fla., Sept. 16 -- Imaging Diagnostic Systems Inc. announced that it has received patent issue notification from the US Patent and Trademark Office for the company's laser imaging device employing biomedical markers that bind to cancer cells. The fluorescence CTLM scanner uses fluorescent markers, which distinguish cancerous cells from healthy cells, to localize the cancerous tissue.